Status:
COMPLETED
Ulmus Macrocarpa Hance Extract and Lipid Profile
Lead Sponsor:
Sang Yeoup Lee
Conditions:
Dyslipidemias
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the Ulmus Macrocarpa Hance extract on lipid profile in adults with dyslipidemia for 12 week...
Detailed Description
Previous another our study have indicated that Ulmus Macrocarpa Hance extract (UMH) may have the ability to decrease blood cholesterol. Therefore, the investigators conduct a randomized, double-blind,...
Eligibility Criteria
Inclusion
- LDL cholesterol ranging from 130 to 190 mg/dL
Exclusion
- Abnormal liver or renal function (i.e., serum aminotransferase activity \> 80 IU/L and serum creatinine concentrations \> 1.2 mg/dL)
- Diabetes (diagnosed clinically or fasting glucose level \> 126 mg/dL)
- History of ischemic heart disease or cerebrovascular disease
- Uncontrolled hypertension
- History of serious cardiac disease such as angina or myocardial infarction
- History of gastrectomy
- History of medication for psychiatric disease
- Administration of oriental medicine including herbs within the past 4 weeks
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03773315
Start Date
December 1 2018
End Date
February 28 2020
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Integrated Research Institute for Natural Ingredients and Functional Foods
Yangsan, South Korea, 50612